Clincosm LogoSign in Get a demo

Sjogren's Syndrome

Showing NaN - NaN of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 24, 2022

The Pathogenesis and Natural History of Sjogren s Syndrome

Recruiting
  • Pathogenesis
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Salivary Gland Dysfunction and Sjogren's Syndrome

    Completed
    • Lymphoma
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 14, 2019

      Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and

      Completed
      • Sjogren's Syndrome
      • Oral Health
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 23, 2019

        Sjögren's Syndrome, Xerostomia Trial run by the NIDCR (Dexamethasone Parotid Irrigation, Placebo Parotid Irrigation)

        Terminated
        Has Results
        • Sjögren's Syndrome
        • Xerostomia
        • Dexamethasone Parotid Irrigation
        • Placebo Parotid Irrigation
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Nov 1, 2018

        Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome

        Completed
        • Sjogren's Syndrome
        • Dysautonomia
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jul 3, 2018

          Evaluation of Salivary Gland Dysfunction

          Terminated
          • Sjogren's Syndrome
          • Salivary Gland
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Jun 30, 2017

            Sjogren's Syndrome Trial run by the NIDCR (Raptiva)

            Terminated
            Has Results
            • Sjogren's Syndrome
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Nov 17, 2015

            Lacrimal Apparatus Disease, Salivary Gland Disease, Sjogren's Syndrome Trial run by the NIDCR (Dehydroepiandrosterone)

            Completed
            • Lacrimal Apparatus Disease
            • +3 more
            • Bethesda, Maryland
              National Institute of Dental And Craniofacial Research (NIDCR)
            Mar 3, 2008

            Sjogren's Syndrome, Xerostomia Trial run by the NIDCR (Thalidomide)

            Completed
            • Sjogren's Syndrome
            • Xerostomia
            • Bethesda, Maryland
              National Institute of Dental And Craniofacial Research (NIDCR)
            Mar 3, 2008

            Keratoconjunctivitis Sicca, Sjogren's Syndrome Trial run by the NEI (Cyclosporin A)

            Completed
            • Keratoconjunctivitis Sicca
            • Sjogren's Syndrome
            • Cyclosporin A
            • Bethesda, Maryland
              National Eye Institute (NEI)
            Mar 3, 2008

            Sjogren's Syndrome Trial run by the NIDCR (Etanercept)

            Completed
            • Sjogren's Syndrome
            • Bethesda, Maryland
              National Institute of Dental And Craniofacial Research (NIDCR)
            Mar 3, 2008

            The Functioning of Immune and Hormonal Systems in Sjogren's

            Completed
            • Sjogren's Syndrome
              • Bethesda, Maryland
                National Institute of Dental And Craniofacial Research (NIDCR)
              Mar 3, 2008

              Potential of Transplanted Stem Cells to Mature Into Salivary

              Completed
              • Graft vs Host Disease
              • Sjogren's Syndrome
                • Bethesda, Maryland
                  National Institute of Dental And Craniofacial Research (NIDCR)
                Mar 3, 2008